To review ACS's full commitment, read the ACS Statement on Diversity, Equity, Inclusion, and Respect. Learn how to make science communication more accessible to people with disabilities, and ...

Key guidance to industry on enhancing diversity in clinical trials of cancer drugs disappeared from ... s push to terminate diversity, equity, inclusion, and accessibility programs and initiatives.

The Food and Drug Administration has removed webpages about diversity and inclusion in clinical trials for cancer drugs. The page for Project Equity, a 2021 initiative launched by the FDA's ...